BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products

ANAHEIM, CA — (Marketwired) — 01/12/17 — (OTC PINK: BICX) (the “Company”), a developer and provider…

Continue Reading